ETNB logo

89bio, Inc. (ETNB)

Profile

Full Name

89bio, Inc.

Ticker

NASDAQ: ETNB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 11, 2019

Indexes

Not included

Website

https://www.89bio.com

Employees

93

Key Details

Price

$14.80(0.00%)

Market Cap

$2.20B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$3.51(-75.47% YoY)

PE Ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.80
    ETNB price is $14.80

    30-Day Relative Volume

    0.25
    ETNB 30-day relative volume is 0.25

    Price Performance

    Price Most Recent Change

    0%
    ETNB price has remained unchanged on Oct 13, 2025

    Price YTD Change

    +89.26%
    ETNB price is up +89.26% since January 1st

    Price 1-Year Change

    +89.99%
    ETNB price is up +89.99% year-on-year

    Price 3-Year Change

    +84.77%
    ETNB price is up +84.77% over the past 3 years

    Price Range

    Price All-Time High

    $47.25
    ETNB price is currently -68.68% below its historical high of $47.25

    Price 3-Year Low

    $4.16
    ETNB price is currently +255.77% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.20B
    ETNB market cap is $2.20 billion

    Market Cap 3-Year Change

    +528.93%
    ETNB market cap is up +528.93% over the past 3 years

    Market Cap All-Time High

    $2.22B
    ETNB market cap is currently -1.07% below its historical high of $2.22 billion

    Market Cap Sector Percentile

    80.94%
    ETNB market cap is higher than 80.94% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +39.92%
    ETNB shares outstanding is up +39.92% year-on-year

    Shares Outstanding 3-Year Change

    +240.39%
    ETNB shares outstanding is up +240.39% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.67
    ETNB beta is 1.67

    200-day SMA

    $9.32
    ETNB price is currently +58.87% above its 200-day simple moving average

    50-day SMA

    $11.06
    ETNB price is currently +33.79% above its 50-day simple moving average

    14-Day RSI

    77.66
    ETNB 14-day relative strength index is 77.66

    Volume

    0.25
    ETNB 30-day relative volume is 0.25

    ATR

    $0.32
    ETNB average true range is $0.32

    10-day Historical Volatility

    6.48%
    ETNB 10-day historical volatility is 6.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ETNB annual revenue is $0.00

    Revenue Analysts Estimate

    -
    ETNB annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    ETNB annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.7%
    ETNB annual revenue is higher than 28.7% of companies in Healthcare sector

    EPS

    EPS

    -$3.51
    ETNB annual earnings per share is -$3.51

    EPS Analysts Estimate

    -$2.18
    ETNB annual earnings per share is currently -60.61% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -75.47%
    ETNB annual earnings per share is down -75.47% year-on-year

    EPS Sector Percentile

    26.84%
    ETNB annual earnings per share is higher than 26.84% of companies in Healthcare sector

    Profit

    Gross Profit

    -$38.00K
    ETNB annual gross profit is -$38.00 thousand

    Gross Margin

    -
    ETNB annual gross profit margin value is unknown

    Operating Profit

    -$384.66M
    ETNB annual operating income is -$384.66 million

    Operating Margin

    -
    ETNB annual operating profit margin value is unknown

    Net Income

    -$367.08M
    ETNB annual net profit is -$367.08 million

    Net Margin

    -
    ETNB annual net profit margin value is unknown

    Expenses

    Total Expenses

    $384.66M
    ETNB annual total expenses is $384.66 million

    Operating Expenses

    $384.66M
    ETNB annual total operating expenses is $384.66 million

    Cost Of Goods Sold

    $38.00K
    ETNB annual cost of goods sold is $38.00 thousand

    Selling, General & Administrative Expenses

    $39.62M
    ETNB annual SG&A is $39.62 million

    Depreciation & Amortization

    $38.00K
    ETNB annual D&A is $38.00 thousand

    Interest Expense

    $0.00
    ETNB annual interest expense is $0.00

    Income Tax

    $692.00K
    ETNB annual income tax is $692.00 thousand

    EBIT & EBITDA

    EBIT

    -$361.10M
    ETNB annual earnings before interest & taxes is -$361.10 million

    EBITDA

    -$361.06M
    ETNB annual EBITDA is -$361.06 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $478.69M
    ETNB annual total assets is $478.69 million

    Non Current Assets

    $2.23M
    ETNB annual long term assets is $2.23 million

    Current Assets

    $476.45M
    ETNB annual total current assets is $476.45 million

    Cash and Cash Equivalents

    $126.06M
    ETNB annual cash & cash equivalents is $126.06 million

    Accounts Receivable

    -
    ETNB annual accounts receivable value is unknown

    Inventory

    $0.00
    ETNB annual inventory is $0.00

    Liabilities

    Total Liabilities

    $77.90M
    ETNB annual total liabilities is $77.90 million

    Long Term Liabilities

    $41.77M
    ETNB annual total long term liabilities is $41.77 million

    Current Liabilities

    $36.13M
    ETNB annual current liabilities is $36.13 million

    Accounts Payable

    $15.38M
    ETNB annual accounts payable is $15.38 million

    Debt

    Total Debt

    $37.55M
    ETNB annual total debt is $37.55 million

    Total Debt 1-Year Change

    +38.52%
    ETNB annual total debt is up +38.52% year-on-year

    Long Term Debt

    $36.82M
    ETNB annual long term debt is $36.82 million

    Short Term Debt

    $727.00K
    ETNB annual short term debt is $727.00 thousand

    Equity & Capital

    Shareholders Equity

    $400.79M
    ETNB annual stockholders equity is $400.79 million

    Book Value

    $400.79M
    ETNB annual book value is $400.79 million

    Retained Earnings

    -$824.51M
    ETNB annual retained earnings is -$824.51 million

    Working Capital

    $440.32M
    ETNB annual working capital is $440.32 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$367.82M
    ETNB annual cash from operations is -$367.82 million

    Cash From Operations 1-Year Change

    -184.72%
    ETNB annual cash from operations is down -184.72% year-on-year

    Cash From Investing

    -$40.86M
    ETNB annual cash from investing is -$40.86 million

    Cash From Investing 1-Year Change

    +66.78%
    ETNB annual cash from investing is up +66.78% year-on-year

    Cash From Financing

    $218.59M
    ETNB annual cash from financing is $218.59 million

    Cash From Financing 1-Year Change

    -57.4%
    ETNB annual cash from financing is down -57.4% year-on-year

    CAPEX

    CAPEX

    $15.00K
    ETNB annual capital expenditures is $15.00 thousand

    CAPEX 1-Year Change

    +275%
    ETNB annual capital expenditures is up +275% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$367.84M
    ETNB annual free cash flow is -$367.84 million

    Free Cash Flow 1-Year Change

    -184.73%
    ETNB annual free cash flow is down -184.73% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    ETNB annual gross profit margin value is unknown

    Operating Margin

    -
    ETNB annual operating profit margin value is unknown

    Net Margin

    -
    ETNB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -68.30%
    ETNB annual return on assets is -68.30%

    ROE

    -78.34%
    ETNB annual return on equity is -78.34%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ETNB price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ETNB price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    4.21
    ETNB price to book ratio is 4.21

    PB Ratio Sector Percentile

    72.36%
    ETNB price to book ratio is higher than 72.36% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    ETNB price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    ETNB price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $1.67B
    ETNB enterprise value is $1.67 billion

    Enterprise Value Sector Percentile

    78.13%
    ETNB enterprise value is higher than 78.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.78
    ETNB EV/EBITDA is -3.78

    EV/EBITDA Sector Percentile

    29.31%
    ETNB EV/EBITDA is higher than 29.31% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    13.19
    ETNB annual current ratio is 13.19

    Quick Ratio

    13.19
    ETNB annual quick ratio is 13.19

    Leverage

    Debt To Equity

    0.09
    ETNB annual debt to equity ratio is 0.09

    Interest Coverage Ratio

    -
    ETNB annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ETNB piotroski f-score value is unknown

    Altman Z-Score

    13.13
    ETNB altman z-score is 13.13

    Analyst ratings

    Recent major analysts updates

    Sep 19, 25 Wolfe Research
    Peer Perform
    Sep 19, 25 Raymond James
    Market Perform
    Sep 19, 25 HC Wainwright & Co.
    Neutral
    Aug 25, 25 B of A Securities
    Buy
    Aug 8, 25 RBC Capital
    Sector Perform
    Mar 14, 25 Goldman Sachs
    Neutral
    Mar 13, 25 Citigroup
    Buy
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 4, 25 Wolfe Research
    Outperform
    Jan 31, 25 UBS
    Buy

    Institutional Ownership

    Screeners with ETNB included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for 89bio, Inc.?
    • Does 89bio, Inc. pay dividends?
    • What sector is 89bio, Inc. in?
    • What industry is 89bio, Inc. in?
    • What country is 89bio, Inc. based in?
    • When did 89bio, Inc. go public?
    • Is 89bio, Inc. in the S&P 500?
    • Is 89bio, Inc. in the NASDAQ 100?
    • Is 89bio, Inc. in the Dow Jones?
    • When was 89bio, Inc.'s last earnings report?
    • When does 89bio, Inc. report earnings?

    What is the ticker symbol for 89bio, Inc.?

    The ticker symbol for 89bio, Inc. is NASDAQ:ETNB

    Does 89bio, Inc. pay dividends?

    No, 89bio, Inc. does not pay dividends

    What sector is 89bio, Inc. in?

    89bio, Inc. is in the Healthcare sector

    What industry is 89bio, Inc. in?

    89bio, Inc. is in the Biotechnology industry

    What country is 89bio, Inc. based in?

    89bio, Inc. is headquartered in United States

    When did 89bio, Inc. go public?

    89bio, Inc.'s initial public offering (IPO) was on November 11, 2019

    Is 89bio, Inc. in the S&P 500?

    No, 89bio, Inc. is not included in the S&P 500 index

    Is 89bio, Inc. in the NASDAQ 100?

    No, 89bio, Inc. is not included in the NASDAQ 100 index

    Is 89bio, Inc. in the Dow Jones?

    No, 89bio, Inc. is not included in the Dow Jones index

    When was 89bio, Inc.'s last earnings report?

    89bio, Inc.'s most recent earnings report was on August 5, 2025

    When does 89bio, Inc. report earnings?

    The next expected earnings date for 89bio, Inc. is November 6, 2025
    On this page